Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ENDP

Endo (ENDP)

Endo International PLC

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ENDP

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
21/09/2023	13h45	PR Newswire (Canada)	Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting	NASDAQ:ENDP	Endo International PLC
21/09/2023	13h45	PR Newswire (US)	Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting	NASDAQ:ENDP	Endo International PLC
08/08/2023	13h45	PR Newswire (US)	ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
08/08/2023	13h45	PR Newswire (Canada)	ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
18/07/2023	22h30	PR Newswire (US)	Endo Launches Bivalirudin Injection in Ready-to-Use Vials	NASDAQ:ENDP	Endo International PLC
13/07/2023	22h30	PR Newswire (US)	Endo Presents New Data at the American Podiatric Medical Association Annual Meeting	NASDAQ:ENDP	Endo International PLC
29/06/2023	22h31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
12/06/2023	13h30	PR Newswire (US)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
12/06/2023	13h30	PR Newswire (US)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
12/06/2023	13h30	PR Newswire (Canada)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
08/05/2023	13h37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
08/05/2023	13h30	PR Newswire (US)	ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
17/04/2023	13h45	PR Newswire (US)	Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program	NASDAQ:ENDP	Endo International PLC
03/04/2023	22h30	PR Newswire (Canada)	Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension	NASDAQ:ENDP	Endo International PLC
03/04/2023	22h30	PR Newswire (US)	Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension	NASDAQ:ENDP	Endo International PLC
13/03/2023	21h17	PR Newswire (US)	Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis	NASDAQ:ENDP	Endo International PLC
10/03/2023	13h30	PR Newswire (US)	Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules	NASDAQ:ENDP	Endo International PLC
06/03/2023	22h14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ENDP	Endo International PLC
06/03/2023	15h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
06/03/2023	15h28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
27/02/2023	23h15	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
27/02/2023	23h10	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
27/02/2023	23h05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
27/02/2023	23h00	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:ENDP	Endo International PLC
14/02/2023	15h00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
13/02/2023	18h39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENDP	Endo International PLC
06/02/2023	13h30	PR Newswire (US)	Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease	NASDAQ:ENDP	Endo International PLC
31/01/2023	23h06	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ENDP	Endo International PLC
22/12/2022	22h24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
06/12/2022	22h45	PR Newswire (US)	Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)	NASDAQ:ENDP	Endo International PLC

Showing the most relevant articles for your search:NASDAQ:ENDP

1 2 3 4 5 6 7 8 9 10 Next >>

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen